Cannabinoids and the Aging Brain: Why Dose and Product Type Matter
A review in Frontiers in Pharmacology examined dose-effect complexities and challenges in cannabinoid therapy for aging-related neurobiological changes. Dr. Caplan reviews this cannabinoids aging brain dose research and why the same product can behave…
Personalized Cannabis Care in Massachusetts: Comprehensive Clinical Consultations
Discover personalized cannabis care at CED Clinic. Comprehensive clinical evaluations with Dr. Benjamin Caplan focused on whole-person wellness, drug interaction screening, and precise cannabinoid dosing.
Endocannabinoid System and Opioids: What a New Review Says About Pain and OUD
A review in Expert Opinion on Therapeutic Targets examined therapeutic activation of the endocannabinoid system for opioid use disorder, chronic pain, and cancer-related pain. Dr. Caplan reviews this endocannabinoid system opioid use disorder research…
Cannabinoids in Psychiatric Care: What New Clinical Trials Reveal About CBD & Psychosis
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Brain FAAH Binding Rises During Early Cannabis Abstinence in a Small PET Study
medical cannabis research: A small longitudinal PET study found increased brain FAAH binding during early cannabis abstinence. Associations with depression and impulsivity suggest research directions, but the findings do not establish a withdrawal…
Cannabis Use With GLP-1 Therapy: What a Diabetes Cohort Found
A propensity score-matched cohort study in Drug and Alcohol Dependence examined cardiovascular, renal, and mortality outcomes among patients with type 2 diabetes on GLP-1 receptor agonists who also use cannabis. Dr. Caplan reviews this cannabis use GLP-1…
Cannabinoids in Oncology: Preclinical Signals, Tumor Pathways, and Clinical Trials
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Progesterone for Cannabis Use Disorder: What the New Stress-Response Trial Actually Found
A randomized, placebo-controlled trial in Psychopharmacology tested progesterone in cannabis use disorder and examined sex differences in stress responding. Dr. Caplan reviews this progesterone cannabis use disorder trial and what a hormonal treatment…
Rat Study Links Cannabis Nanoemulsions to Salivary Gland Injury
medical cannabis research: A 21-day rat study found salivary gland tissue changes after oral cannabis nanoemulsions, with isolated CBD producing more injury than CBD plus THC. Human relevance remains uncertain. The main study limits remain important for…
Cannabinoids and Autoimmune Disease: What a New Literature Review Says About the Immune Mechanism Gap
A literature review in Revue de Medecine Interne examined the clinical immunomodulatory effects of cannabinoids in autoimmune diseases within internal medicine. Dr. Caplan reviews this cannabinoids autoimmune disease research and the gap between…
